TREATMENT OF CANCER WITH S1P RECEPTOR AGONISTS

Abstract: the present disclosure relates to a s1p receptor agonist, for use in treating cancer in a subject in need thereof, wherein said subject does not undergo hematopoietic stem cell transplant (hsct) for cancer therapy.

Inventor(s): Stephan OEHEN, Simone DERTSCHNIG, Philippe BOUSSO, Morgane BOULCH

CPC Classification: A61K31/145 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250213503